Plasma CTGF levels were reported to be elevated in IPF patients (16) and, together with Vascular Endothelial Growth Factor (VEGF) and TGF-β, act as central mediators in fibrosis (14, 17–19). The gene discussed is VEGFA; the disease is idiopathic pulmonary fibrosis.